Search

Displaying results 7571 - 7580 of 10000 in total
  1. Drug

    BCL-005

    go.drugbank.com/drugs/DB17242
    Experimental

    BCL-005 is a product formed by fused (hybrid) melanoma-dendritic cells.

  2. Drug

    Desmethylprodine

    go.drugbank.com/drugs/DB01478
    ExperimentalIllicit

    Desmethylprodine, a derivative of meperidine, is an opioid analgesic with the potency of morphine. … It has been listed as a Schedule I controlled drug in the United States, and thus is not used clinically. It is known to be a designer drug, synthesized in 1977, for the purpose of recreational use.

  3. Drug

    CX157

    go.drugbank.com/drugs/DB05205
    Investigational

    CX157,3-fluoro-7-(2,2,2,-trifluoroethoxy)phenoxathiin-10,10-dioxide, is a reversible, selective inhibitor of MAO-A designed to have improved oral bioavailability and reduced clearance compared to previous

  4. Drug

    ISB 1442

    go.drugbank.com/drugs/DB18475
    Investigational

    ISB 1442 is a bispecific, biparatopic antibody targeting CD38 and CD47

  5. Drug

    Dilanubicel

    go.drugbank.com/drugs/DB18722
    Investigational

    Dilanubicel consists of ex vivo expanded hematopoietic stem and progenitor cells.

  6. Drug

    SB 11285

    go.drugbank.com/drugs/DB17511
    Investigational

    [L45123] SB 11285 is under investigation in clinical trial NCT04096638 (Evaluating Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors).

  7. Drug

    Escin

    go.drugbank.com/drugs/DB15907
    Investigational

    prognosis in massive cerebral infarction) and NCT05263167 (aimed at reducing edema after intracerebral hemorrhage). … Sodium aescinate is under investigation in clinical trials for its potential to treat cerebral conditions, including NCT04247659 (studying the relationship between asymmetric vascular sign of cortex and

  8. Drug

    SW033291

    go.drugbank.com/drugs/DB32765
    Experimental

    [A275473, A275474] It has been found to increase prostaglandin E2 (PGE2) and is being investigated in accelerating of hematopoietic recovery and treating type 2 diabetes mellitus.[A275473, A275474]

  9. Drug

    BIIB021

    go.drugbank.com/drugs/DB12359
    Investigational

    BIIB021 has been investigated for the treatment of Tumors and Lymphoma.

  10. Drug

    Selurampanel

    go.drugbank.com/drugs/DB12367
    Investigational

    Selurampanel has been investigated in Adrenocortical Adenoma and Sarcoma, Endometrial Stromal.